Genotropin

Pediatric Uses

Genotropin is prescribed for children who experience growth failure due to various medical conditions that prevent them from reaching a typical height. These conditions include:

• Growth Hormone Deficiency (GHD): A condition where the pituitary gland does not produce enough natural growth hormone.
• Prader-Willi Syndrome (PWS): A genetic disorder where the medication is used to improve growth and body composition.
• Small for Gestational Age (SGA): For children born smaller than average who do not catch up to a normal height range by age two.
• Turner Syndrome: A chromosomal condition in females that often results in short stature.
• Idiopathic Short Stature (ISS): For children who are significantly shorter than their peers for no known medical reason and are unlikely to reach a typical adult height.

Adult Uses

In adults, Genotropin is used as a replacement therapy for growth hormone deficiency. This deficiency may be a continuation of a condition that began in childhood, or it may develop in adulthood due to factors such as pituitary disease, surgery, head trauma, or radiation therapy. Treatment in adults is intended to restore growth hormone to healthy levels rather than to increase height.

Mechanism of Action

Genotropin contains somatropin, which is a recombinant form of human growth hormone. It is designed to be identical to the hormone naturally produced by the pituitary gland. Once injected, it travels through the bloodstream and attaches to growth hormone receptors on various cells in the body.

Promoting Growth

In children whose bodies do not produce enough natural growth hormone, or who have certain medical conditions, Genotropin works to stimulate linear growth. It achieves this by:

• Increasing the length of long bones at the growth plates.
• Increasing the number and size of muscle cells.
• Promoting the development and size of internal organs.

Metabolic Effects

Beyond physical height, Genotropin influences how the body manages energy and nutrients. It affects metabolism in several ways:

• Protein synthesis: It encourages cells to build more protein and helps the body retain nitrogen, which is essential for tissue repair and growth.
• Fat metabolism: It stimulates the breakdown of fats and reduces the amount of fat stored in the body.
• Carbohydrate metabolism: It plays a role in regulating blood sugar levels and how the body responds to insulin.

Common Side Effects

Many people using Genotropin experience mild side effects. These often improve as the body adjusts to the medication. Common symptoms include:

• Pain, redness, itching, or swelling where the medicine was injected
• Joint or muscle pain and stiffness
• Swelling in the hands, feet, or lower legs
• Headache
• Cold or flu-like symptoms

Serious Side Effects

While less common, some side effects require immediate medical attention. Contact a healthcare provider if you experience:

• Increased pressure in the brain: Symptoms include severe headaches, nausea, vomiting, and vision changes.
• High blood sugar: Signs include increased thirst, frequent urination, and fatigue.
• Bone or joint issues: New or worsening limping, or pain in the hip or knee.
• Pancreatitis: Severe pain in the upper stomach that may spread to the back.
• Skin changes: New moles or changes in the size or color of existing moles.
• Severe allergic reactions: Swelling of the face, lips, or tongue, severe rash, or difficulty breathing.

Serious Risks and Contraindications

Genotropin should not be used in patients with active cancer, certain types of eye damage caused by diabetes (diabetic retinopathy), or acute critical illness resulting from major surgery, trauma, or respiratory failure. In children with Prader-Willi syndrome, the medication is contraindicated if they are severely obese or have severe breathing problems, as sudden death has been reported in these cases.

Monitoring and Metabolic Effects

Treatment with somatropin may affect how the body processes sugar, potentially leading to glucose intolerance or new-onset type 2 diabetes. Regular monitoring of blood glucose levels is necessary, especially for those with existing risk factors. Additionally, the medication can impact thyroid and adrenal gland function, which may require adjustments to other hormone replacement therapies.

Neurological and Vision Concerns

A condition called intracranial hypertension, which involves increased pressure inside the skull, can occur. Symptoms may include persistent headaches, nausea, vomiting, or changes in vision. Healthcare providers typically perform eye exams before and during treatment to check for swelling of the optic disc.

Physical and Structural Changes

• Bone and Joint Issues: Children may experience a slipped growth plate in the hip (slipped capital femoral epiphysis) or a worsening of existing scoliosis. Any new limp or hip and knee pain should be evaluated.
• Fluid Retention: Adults may experience swelling (edema), joint pain, or carpal tunnel syndrome due to fluid retention.
• Pancreatitis: Severe and persistent abdominal pain should be reported immediately, as this may indicate inflammation of the pancreas.
• Injection Site Reactions: To prevent the breakdown of fat tissue (lipoatrophy), injection sites should be rotated regularly.

Pregnancy

There are no adequate and well-controlled studies of Genotropin in pregnant women. Animal reproduction studies have not been conducted with this specific medication. Because it is unknown whether Genotropin can cause fetal harm or affect reproductive capacity, it is generally recommended for use during pregnancy only if the potential benefit justifies the potential risk to the fetus.

If you are pregnant or planning to become pregnant, it is important to discuss the necessity of growth hormone therapy with your healthcare provider.

Breastfeeding

It is not known whether Genotropin is excreted in human milk. Because many medications are passed into breast milk, caution should be exercised when Genotropin is administered to someone who is breastfeeding. Healthcare providers typically evaluate the importance of the medication to the mother alongside the potential risks to the nursing infant before recommending its use during lactation.

Available Forms

Genotropin is provided as a lyophilized powder for subcutaneous injection. It must be mixed with a diluent before administration. The medication is available in several delivery formats designed to facilitate the mixing and injection process:

• Two-Chamber Cartridges: These cartridges contain the powder in one chamber and the liquid diluent in the other. They are intended for use with a compatible reusable delivery pen.
• Single-Use Pre-filled Syringes: These are disposable, one-time-use devices that also feature a two-chamber design for mixing the medication immediately before injection.

The specific delivery system used depends on the prescribed dose and the patient's needs. Both formats are designed to ensure the medication is properly reconstituted without the need for separate vials and syringes.

FDA Approval and Indications

Genotropin is a recombinant human growth hormone approved by the U.S. Food and Drug Administration (FDA). It is used to treat growth failure in pediatric patients and growth hormone deficiency in adults.

Approved Pediatric Indications

• Growth hormone deficiency (GHD)
• Prader-Willi syndrome (PWS)
• Small for gestational age (SGA) with no catch-up growth by age 2
• Turner syndrome
• Idiopathic short stature (ISS)

Approved Adult Indications

Genotropin is indicated for adults with growth hormone deficiency that originated in either childhood or adulthood. Diagnosis must be confirmed by appropriate growth hormone stimulation testing, except in specific cases of multiple pituitary hormone deficiencies.

Safety and Contraindications

The FDA has identified several conditions where Genotropin should not be used. These contraindications include:

• Acute critical illness resulting from certain types of surgery, trauma, or respiratory failure.
• Active cancer or tumors.
• Severe vision problems caused by diabetes (diabetic retinopathy).
• Children whose growth plates (epiphyses) have already closed.

Specific safety warnings apply to patients with Prader-Willi syndrome. The medication is contraindicated for those with Prader-Willi syndrome who are severely obese or have severe respiratory problems, as there have been reports of sudden death in these patients when using somatropin.

Factors Influencing Cost

The total price of Genotropin treatment is primarily determined by the patient's weight and the specific medical condition being treated, as these factors dictate the required dosage. Because Genotropin is often used for long-term therapy, the cumulative cost can be significant over time.

Insurance and Prior Authorization

Many insurance providers require prior authorization before they will cover Genotropin. This process involves the healthcare provider submitting documentation to the insurance company to prove the medication is medically necessary. Out-of-pocket costs, such as copays or coinsurance, will vary depending on the individual's specific insurance plan and pharmacy benefits.

Financial Assistance Programs

The manufacturer of Genotropin offers support programs, such as the Pfizer Bridge Program, which may help eligible patients with insurance navigation or provide the medication at a reduced cost for those who qualify based on financial need. Patients are encouraged to speak with their healthcare provider or the manufacturer directly to explore these options.

Biosimilars and Alternatives

While Genotropin is a brand-name medication, there are other somatropin products available, including biosimilars. Biosimilars are highly similar to the original brand-name drug and may be available at a lower price point, though they are not always interchangeable without a specific prescription from a doctor.